PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 18, 20251 citations

Supply Chain Role in Cost Reduction, Predictability & Reliability in Pharmaceutical Industry

View Full Paper
GGGirish Gupta

Key Points

  • Optimized pharmaceutical supply chains achieve cost reductions between 15-25%, alongside improved service reliability.
  • Key metrics show accuracy in demand forecasts can improve by 20-35%, enhancing operational effectiveness significantly.
  • This assessment employs a quantitative analysis on the role of strategic sourcing and advanced technologies in supply chains.
  • The implications highlight the need for evolving towards patient-centric models to balance cost, accessibility, and regulatory compliance.

Abstract

The pharmaceutical supply chain represents a complex ecosystem that directly impacts cost efficiency, demand predictability, and supply reliability across the global healthcare system. This research examines how modern pharmaceutical supply chains contribute to cost reduction through strategic sourcing, manufacturing optimization, inventory management, and distribution efficiency. The study analyzes predictability mechanisms including demand forecasting, supply planning, and risk management systems that enable pharmaceutical companies to anticipate market needs and maintain service levels. Reliability factors encompass quality assurance, regulatory compliance, supplier performance management, and business continuity planning. Key findings reveal that optimized pharmaceutical supply chains achieve 15-25% cost reductions, improve forecast accuracy by 20-35%, and maintain 98%+ service reliability levels. The research demonstrates that integrated supply chain management combining digital technologies, strategic partnerships, and operational excellence enables pharmaceutical companies to balance competing objectives of cost minimization, service predictability, and supply reliability. Advanced analytics, artificial intelligence, and blockchain technologies are emerging as critical enablers for next-generation pharmaceutical supply chain performance. The study concludes that successful pharmaceutical supply chains must evolve toward patient-centric models that prioritize accessibility, affordability, and availability while maintaining profitability and regulatory compliance in an increasingly complex global marketplace.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Girish Gupta (2025) studied this question.

synapsesocial.com/papers/68d462ca31b076d99fa6209chttps://doi.org/10.54660/.ijfmr.2025.6.1.310-315
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Enhancing Pharmaceutical Supply Chain Performance2025
  2. 2The Role and Challenges of Supply Chain Management within U.S. Pharmaceutical Organizations2025 · 1 citations
  3. 3Building Resilient And Efficient Supply Chains In Healthcare And Pharmaceuticals: A Strategic Perspective2026
  4. 4Building Resilient And Efficient Supply Chains In Healthcare And Pharmaceuticals: A Strategic Perspective2026
  5. 5Strategies for Developing a Future-Ready Pharmaceutical Supply Chain2025